Vanguard Personalized Indexing Management
FOLD

Vanguard Personalized Indexing Management’s Amicus Therapeutics FOLD Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-36,983
Closed -$535K – 2288
2026
Q1 		$535K Buy
36,983
+12,822
+53% +$184K 0.01% 1272
2025
Q4 		$344K Sell
24,161
-538
-2% -$5.29K ﹤0.01% 1443
2025
Q3 		$195K Buy
24,699
+6,812
+38% +$48.5K ﹤0.01% 1716
2025
Q2 		$102K Buy
17,887
+6,932
+63% +$44.7K ﹤0.01% 1734
2025
Q1 		$89.4K Sell
10,955
-8,394
-43% -$77.7K ﹤0.01% 1624
2024
Q4 		$182K Buy
19,349
+9,292
+92% +$96.6K ﹤0.01% 1540
2024
Q3 		$107K Buy
+10,057
New +$110K ﹤0.01% 1605
2023
Q4 		– Sell
-14,995
Closed -$182K – 1589
2023
Q3 		$182K Sell
14,995
-483
-3% -$6.23K 0.01% 1319
2023
Q2 		$194K Buy
15,478
+1,716
+12% +$20.4K 0.01% 1336
2023
Q1 		$153K Buy
13,762
+1,649
+14% +$20.3K 0.01% 1364
2022
Q4 		$148K Buy
+12,113
New +$136K 0.01% 1191

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Vanguard Personalized Indexing Management's FOLD Position: Q2 2026 in Review

Vanguard Personalized Indexing Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 36,983 shares — an estimated $535K sold.

Vanguard Personalized Indexing Management first reported a position in FOLD in Q4 2022 and held it in 11 quarters. The position peaked at $535K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Vanguard Personalized Indexing Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 36,983 Amicus Therapeutics shares in Q2 2026, an estimated $535K.
  • Vanguard Personalized Indexing Management first reported a position in Amicus Therapeutics in Q4 2022 and held it in 11 quarters.
  • Vanguard Personalized Indexing Management's Amicus Therapeutics position peaked at $535K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.